Multi-Omics Integration in Veterinary Viral Diagnostics

Overview and Principles of Multi-Omics Integration in Veterinary Viral Diagnostics

The contemporary landscape of veterinary viral diagnostics is undergoing a profound paradigm shift, moving away from the traditional, reductionist approach of single-pathogen detection towards a holistic, systems-level interrogation of host-pathogen ecosystems. This transformation is driven by the maturation of high-throughput omics technologies and the concomitant realization that clinical outcome in viral disease is rarely determined by the pathogen alone but emerges from a complex interplay of viral genetics, host susceptibility, immune status, and the resident microbiome. Multi-omics integration-the coordinated analysis of genomics, transcriptomics, proteomics, metabolomics, and meta-omics datasets-offers the only viable framework to capture this biological complexity, transforming raw molecular data into actionable diagnostic, prognostic, and therapeutic intelligence [7, 8, 14]. For the veterinary clinical pathologist, this represents not merely an expansion of the diagnostic toolkit but a fundamental reconceptualization of how we define, detect, and manage viral infections across companion animals, livestock, and wildlife.

The Conceptual Foundation: From Reductionism to Biological Integration

At its core, the principle of multi-omics integration in viral diagnostics rests on the recognition that biological information flows hierarchically-from the static blueprint of the genome, through the dynamic regulation of the transcriptome and proteome, to the functional readout of the metabolome-and that no single layer captures the full pathophysiological state. A virus may integrate into the host genome (genomic layer), dysregulate hundreds of mRNA transcripts (transcriptomic layer), alter protein-protein interaction networks (proteomic layer), and reprogram cellular metabolic flux (metabolomic layer), all while simultaneously perturbing the composition and function of the host's microbial communities (meta-omics layer). Traditional diagnostics, confined to detecting the virus itself via PCR or antigen capture, are inherently blind to these host-response dimensions, which often dictate whether an infection remains subclinical or progresses to severe, life-threatening disease [15, 18]. The diagnostic value of multi-omics lies precisely in its ability to capture this multidimensional host response, providing a "molecular signature" of infection that can stratify patients by disease trajectory, identify co-infections, and reveal mechanisms of pathogenesis and immune evasion long before clinical signs become apparent.

This principle is elegantly illustrated by studies integrating metabolomics and transcriptomics to define host responses to viral infection. For instance, in a multi-omics analysis of chickens infected with nephropathogenic Infectious Bronchitis Virus, researchers combined RNA-seq of kidney tissue with GC-TOF/MS metabolomics and 16S rRNA sequencing of cecal contents to reveal a coordinated dysregulation across immune response pathways, purine and amino acid metabolism, and the gut-kidney axis [6]. This integrated approach not only identified 2,868 differentially expressed genes and 160 altered metabolites but also established novel correlations between the kidney metabolome and shifts in the cecal microbiome, underscoring how a respiratory/renal virus can systemically remodel the host's metabolic and microbial landscape. Similarly, in the context of Avian Hepatitis E Virus infection, an integrative framework linking viral-host interactions with immune-neuroendocrine disruption has revealed how ORF2-mediated receptor binding and ORF3-mediated viral egress synergistically impair ovarian function in laying hens, providing a molecular explanation for the egg production declines that have long puzzled poultry clinicians [13]. These examples demonstrate that multi-omics integration moves viral diagnostics beyond simple agent detection toward a mechanistic understanding of disease causality.

Mechanistic and Technical Underpinnings of the Integrative Framework

The successful implementation of multi-omics diagnostics requires a rigorous understanding of both the biological interrelationships between omic layers and the computational strategies used to fuse them. From a biological perspective, the key principle is that of "vertical integration"-tracing the causal cascade from genetic variation to phenotypic outcome. For example, single nucleotide polymorphisms (SNPs) identified through genomics or GWAS may confer susceptibility or resistance to a given virus, but these genetic variants only exert their effects through alterations in gene expression (transcriptomics), protein abundance and post-translational modification (proteomics), and ultimately metabolic flux (metabolomics). The diagnostic power of integration emerges when these layers are analyzed jointly, allowing the pathologist to construct causal networks rather than mere correlative lists. This approach has been applied to Porcine Reproductive and Respiratory Syndrome Virus infection, where the integration of metabolomic and lipidomic serum analyses with machine learning identified lysophosphatidic acid (LPA) as a key metabolic biomarker diagnostic of PRRSV infection [5]. Importantly, mechanistic follow-up revealed that PRRSV hijacks LPA synthesis via upregulation of autotaxin to suppress RIG-I and type I interferon responses-a finding that would have been invisible to transcriptomics alone but was uncovered through integrative analysis.

From a technical standpoint, multi-omics integration in veterinary diagnostics can be categorized into three broad strategies: concatenation-based, transformation-based, and model-based integration. Concatenation-based approaches simply merge features from all omic layers into a single matrix prior to statistical or machine learning analysis, which is straightforward but can suffer from the "curse of dimensionality" when the number of variables vastly exceeds the number of samples. Transformation-based methods, such as those employing kernel learning or similarity network fusion, project each omic dataset into a common mathematical space before integration, preserving individual data structures while allowing cross-layer comparisons. Model-based approaches, including Bayesian networks, graphical models, and deep learning architectures, explicitly parameterize the relationships between layers and can infer causal directionality. The choice of strategy must be guided by the diagnostic question: concatenation may suffice for simple binary classification (infected vs. uninfected), while model-based integration is essential for identifying mechanistic drivers of divergent clinical trajectories [2, 16]. The application of deep learning to multimodal data-integrating genomic, transcriptomic, and metabolomic information-has been demonstrated in food microbiology contexts and is directly translatable to veterinary virology for comprehensive microbial profiling [2].

The Role of the Microbiome and Metagenomics in the Integrative Diagnostic Paradigm

No discussion of multi-omics principles in veterinary virology would be complete without addressing the critical and often neglected role of the microbiome. The host's resident microbial communities-bacterial, fungal, and viral-constitute a dynamic ecosystem that profoundly modulates susceptibility to viral infection, immune response magnitude, and even viral evolution. Metagenomic and metatranscriptomic approaches, often referred to collectively as "meta-omics," enable the simultaneous profiling of host gene expression and microbial community structure from a single clinical sample. This is particularly relevant in aquaculture, where outbreaks of viral pathogens such as White Spot Syndrome Virus, Infectious Myonecrosis Virus, and Taura Syndrome Virus are often precipitated by environmental stressors that shift the host's microbiome toward dysbiosis, creating permissive conditions for viral replication. Genomic surveillance of antibiotic resistance genes (ARGs) in aquaculture settings, facilitated by whole-genome sequencing and metagenomics, further illustrates how meta-omic data must be integrated to understand the full ecological context of viral disease emergence [1]. The principle of "horizontal integration"-linking pathogen data with microbiome data-thus becomes a cornerstone of modern veterinary diagnostics, acknowledging that the host is not a sterile organism but a complex holobiont whose microbial partners can either protect against or promote viral pathogenesis.

This principle has been formalized in recent frameworks for chronic infections, where the gut microbiome acts as a critical modulator of disease progression. In the context of paratuberculosis-a chronic enteric infection of ruminants caused by Mycobacterium avium subsp. paratuberculosis-the integration of microbiome data with host transcriptomics and metabolomics has revealed a self-sustaining loop of dysbiosis, immune evasion, and pathogen persistence that mirrors mechanisms observed in human Crohn's disease [3]. The diagnostic lesson for veterinary virology is clear: viral infections cannot be fully understood in isolation from the microbial communities in which they occur. A comprehensive diagnostic platform for viruses such as Bovine Viral Diarrhea Virus or Porcine Circovirus 2 must therefore incorporate metagenomic sequencing to rule out concurrent bacterial or fungal infections that may confound clinical presentation and treatment response [11]. The high prevalence of polymicrobial diagnoses in swine-over 50% of cases involving multiple etiologies-underscores the necessity of integrative, rather than single-agent, diagnostic approaches [11].

Integrating Host Response Transcriptomics and Proteomics for Precision Stratification

One of the most clinically impactful applications of multi-omics integration in veterinary viral diagnostics is the use of host transcriptomic and proteomic profiling to stratify patients by disease endotype and predict outcome. Unlike pathogen-detection methods, which provide binary "yes/no" answers, host response profiling captures the functional state of the immune system and can identify individuals at risk for severe disease even when viral load is low. This approach has been validated extensively in human sepsis and COVID-19, where gene expression signatures differentiate viral from bacterial infection with high accuracy and predict progression to critical illness [12, 18]. The translational potential for veterinary medicine is enormous. For diseases such as Canine Distemper Virus, where clinical outcomes range from mild respiratory signs to fatal neurologic disease, a transcriptomic risk score could guide early intervention with antiviral or immunomodulatory therapy. Similarly, in Feline Infectious Peritonitis caused by feline coronavirus, proteomic profiling of effusions could identify the transition from the benign enteric form to the lethal effusive form before traditional diagnostics become positive.

The technical principle underlying these applications is that the host transcriptome and proteome act as "biological integrators," reflecting the net effect of viral virulence factors, host genetics, and environmental exposures. Machine learning algorithms trained on multi-omic data can identify a parsimonious set of biomarkers that capture this integrated state. For example, in a study of seasonal influenza vaccination in humans, multi-omic subtyping of pre-vaccination blood samples-integrating transcriptomics, proteomics, glycomics, and metabolomics-identified five distinct immune states that predicted antibody response with high accuracy [4]. This principle of baseline immune stratification is directly applicable to veterinary vaccinology, where the efficacy of vaccines against pathogens such as Newcastle Disease Virus or Canine Parvovirus varies widely between individuals and populations. The integration of pre-vaccination omic profiles could enable personalized vaccine scheduling or adjuvant selection, dramatically improving herd immunity.

The Imperative of Data Integration and Computational Biology

The practical realization of multi-omics diagnostics in veterinary virology is contingent upon the development of robust bioinformatics infrastructure and analytical pipelines. The sheer volume, variety, and velocity of omic data generated from a single clinical sample-millions of sequencing reads, thousands of protein abundance measurements, hundreds of metabolite concentrations-demand computational approaches that are both scalable and interpretable [10, 14]. The principle of "data harmonization" is paramount: integrating datasets generated on different platforms (e.g., Illumina sequencing for transcriptomics, LC-MS/MS for proteomics, GC-TOF/MS for metabolomics) requires careful normalization to remove technical variation while preserving biological signal. Batch effects, platform-specific biases, and missing data must be addressed through rigorous statistical methods before integration can proceed [19].

Furthermore, the diagnostic utility of multi-omics data depends critically on the availability of species-specific reference databases and annotation pipelines. While human genomics benefits from decades of curated resources, veterinary species-particularly non-model organisms such as fish, crustaceans, and wildlife-often lack comprehensive genome assemblies and functional annotation. This gap is being addressed through ongoing initiatives in comparative genomics and pangenomics, but remains a significant barrier to clinical implementation [9, 17]. The development of cross-species analysis tools, such as those leveraging conserved gene ontologies and pathway databases, will be essential for translating multi-omic discoveries from well-characterized species (e.g., dog, pig, chicken) to less-studied taxa. The integration of immunoinformatics-a discipline combining bioinformatics with immunology-offers a promising avenue for predicting immune epitopes and vaccine targets directly from genomic sequence data, bypassing the need for extensive species-specific experimental data [9].

Finally, the ethical and practical considerations surrounding data ownership, privacy, and consent cannot be overlooked. The generation of comprehensive multi-omic profiles from veterinary patients raises questions about the secondary use of data for breeding selection, insurance purposes, or research. Clear guidelines, analogous to those developed in human genomic medicine, are needed to govern the use of veterinary omic data, ensuring that the diagnostic benefits are realized without compromising animal welfare or owner trust [7, 8]. The integration of multi-omics into veterinary viral diagnostics will ultimately depend on the field's ability to navigate these technical, computational, and ethical challenges while maintaining a steadfast focus on the ultimate goal: improving clinical outcomes for animals through a deeper, more integrated understanding of viral disease.

Methodological Framework for Multi-Omics Data Acquisition and Preprocessing

The integration of multi-omics data for veterinary viral diagnostics necessitates a rigorous, standardized methodological framework that governs every stage from biological sample acquisition through raw data preprocessing to the generation of high-quality, analyzable datasets. This framework must account for the extraordinary diversity of veterinary species, sample matrices, and viral pathogens while maintaining analytical rigor and cross-study comparability. As the field transitions from proof-of-concept studies to clinical and surveillance applications, the establishment of reproducible, scalable, and quality-controlled workflows becomes paramount [7, 14, 17].

Sample Acquisition and Pre-Analytical Variables

The foundation of any multi-omics investigation rests upon meticulous sample collection, stabilization, and storage protocols. In veterinary viral diagnostics, the biological matrix selected must be informed by viral tropism, pathogenesis, and the specific omic layers to be interrogated. For systemic viral infections, whole blood, plasma, or serum remain the most accessible and information-rich samples, enabling concurrent genomic, transcriptomic, proteomic, and metabolomic profiling [5, 12]. However, tissue-specific tropism demands targeted sampling-for instance, renal tissue for nephropathogenic Infectious Bronchitis Virus infections [6], or respiratory tract specimens for pathogens such as Bovine Respiratory Syncytial Virus and Swine Influenza A Virus [11].

Crucially, the temporal dimension of sample acquisition cannot be overstated. For acute viral infections, the host transcriptomic and metabolomic response evolves rapidly over hours to days, with early time points capturing innate immune activation and later time points reflecting adaptive immunity, tissue damage, and repair mechanisms [6, 25]. Studies on Porcine Reproductive and Respiratory Syndrome Virus (PRRSV) have demonstrated that serum metabolomic signatures at the time of peak viremia differ substantially from those during convalescence, and these temporal dynamics must be accounted for in study design [5]. Similarly, investigations into Avian Hepatitis E Virus-induced egg production decline in layers require sampling at defined intervals post-infection to capture the transition from acute viral replication to neuroendocrine disruption [13].

Pre-analytical variables represent a major source of technical variation that can obscure biological signals. Hemolysis, delayed processing, freeze-thaw cycles, and inconsistent anticoagulant use are well-documented confounders in proteomic and metabolomic analyses [12, 33]. For extracellular vesicle (EV)-based analyses, which are emerging as powerful tools for liquid biopsy in veterinary virology, standardized isolation protocols-including differential ultracentrifugation, size-exclusion chromatography, or precipitation-based methods-must be rigorously validated to ensure reproducibility of EV-miRNA and EV-protein cargo [20, 21]. The International Society for Extracellular Vesicles (ISEV) guidelines provide a framework for minimal experimental requirements, but species-specific considerations, such as the high lipid content of avian plasma or the presence of abundant lipoproteins in bovine serum, demand tailored optimization [20, 38].

Nucleic Acid Extraction and Quality Control for Genomic and Transcriptomic Layers

For viral genomic sequencing and host transcriptomic profiling, nucleic acid extraction protocols must balance yield, purity, and integrity while minimizing co-extraction of inhibitors common in veterinary samples, such as heme in blood, polysaccharides in plant tissues, or humic acids in fecal or environmental samples [14, 23]. Automated extraction platforms, such as those evaluated by Xie et al. [23], offer significant advantages in throughput, reproducibility, and reduced cross-contamination-achieving contamination rates as low as 0.0003% in inter-species read mapping assessments. This is particularly critical for metagenomic and metatranscriptomic approaches where low-abundance viral sequences must be distinguished from host or environmental background [19, 27].

RNA integrity remains the single most important quality metric for transcriptomic analyses. The RNA Integrity Number (RIN) threshold for downstream library preparation typically requires values >=7 for poly-A selected RNA-seq, although lower thresholds may be acceptable for ribosomal RNA-depleted total RNA-seq approaches, which are often necessary for viral transcript detection due to the presence of non-polyadenylated viral genomes [22, 24]. For pathogens such as Infectious Salmon Anemia Virus and Viral Hemorrhagic Septicemia Virus, which possess segmented negative-sense RNA genomes, the inclusion of spike-in controls (e.g., External RNA Controls Consortium, ERCC standards) is essential for normalization and absolute quantification of viral transcripts [6].

DNA extraction for viral genomics must consider the diversity of viral genome types encountered in veterinary diagnostics. Double-stranded DNA viruses, such as African Swine Fever Virus, Koi Herpesvirus, and Marek's Disease Virus, are amenable to standard column-based purification. However, single-stranded DNA viruses like Porcine Parvovirus and Canine Parvovirus may require modified lysis conditions to maximize recovery [17, 31]. RNA virus genomes-including those of Classical Swine Fever Virus, Newcastle Disease Virus, and Foot-and-Mouth Disease Virus-require immediate reverse transcription following extraction to generate complementary DNA (cDNA) for downstream sequencing library preparation [14, 28].

Library Preparation Strategies and Multi-Omics Integration

Library preparation represents a critical juncture where methodological choices profoundly impact data quality and biological interpretability. For viral whole-genome sequencing, both amplicon-based and metagenomic approaches have distinct advantages and limitations. Amplicon-based strategies, utilizing multiplexed primer panels targeting conserved viral regions, offer high sensitivity and depth but are inherently biased toward known sequences and may fail to detect novel variants or recombinant strains [19, 37]. Conversely, metagenomic shotgun sequencing provides unbiased detection of all nucleic acids present in a sample, enabling simultaneous characterization of the viral pathogen, host transcriptome, and associated microbiome-a true multi-omics capability within a single sequencing run [10, 27, 35].

The transition to automated library preparation workstations has dramatically improved reproducibility and throughput in veterinary genomics. As demonstrated by Xie et al. [23], automated systems reduce library preparation time from 8-10 hours to 4-6 hours while maintaining Q30 scores >90%, mapping rates >95%, and on-target rates of 85-90%. Critically, the reduction in duplication rates from 10-15% (manual) to 5-8% (automated) indicates increased library complexity, which is essential for accurate detection of low-abundance viral transcripts and rare host splice variants [23]. For transcriptomic analyses, the choice between poly-A enrichment and ribosomal RNA depletion must be guided by the research question. Poly-A enrichment provides deeper coverage of mRNA transcripts but excludes non-polyadenylated RNAs, including many viral genomes and regulatory non-coding RNAs. Ribosomal RNA depletion, while retaining a higher proportion of ribosomal reads (typically 40-60% of total), enables comprehensive analysis of the full transcriptome, including long non-coding RNAs, circular RNAs, and viral transcripts [6, 22].

The emerging application of dual-indexing and unique molecular identifiers (UMIs) has become standard practice in multi-omics studies to mitigate PCR duplication bias and enable absolute quantification. In the context of viral diagnostics, UMIs are particularly valuable for distinguishing true viral sequence variants from sequencing errors, a critical capability for studying within-host viral evolution and quasispecies dynamics in pathogens such as Equine Infectious Anemia Virus and Feline Immunodeficiency Virus [14, 19].

Metagenomic and Metatranscriptomic Preprocessing Pipelines

Metagenomic and metatranscriptomic approaches have revolutionized veterinary viral diagnostics by enabling the simultaneous detection of known and novel pathogens, co-infections, and the host response [27, 35]. However, the computational preprocessing required for these data types is substantially more complex than for single-pathogen targeted sequencing. Raw sequencing reads must undergo rigorous quality filtering, adapter trimming, and removal of low-complexity sequences using tools such as FastQC, Trimmomatic, or Cutadapt [14, 19]. Human and host reference genome subtraction is then performed to enrich for microbial and viral sequences, a step that is particularly challenging in veterinary species with incomplete or poorly annotated reference genomes [17, 36].

For viral detection, multiple complementary bioinformatic approaches are typically employed. Read-based taxonomical classification using kraken2, Centrifuge, or Kaiju rapidly assigns reads to viral taxa based on k-mer matching, while assembly-based approaches using metaSPAdes or MEGAHIT construct contiguous viral genomes from overlapping reads [27, 35]. The integration of both approaches maximizes sensitivity-read-based methods detect viruses present at low abundance, while assembly-based methods provide complete genome sequences necessary for phylogenetic analysis, variant calling, and recombination detection [19, 36]. For RNA viruses, the inclusion of metatranscriptomic data is essential, as DNA-seq alone cannot detect RNA viral genomes or provide information on viral transcriptional activity [10, 27].

A critical consideration in metagenomic preprocessing is the control of false-positive detections arising from index hopping, cross-contamination, or environmental contamination. The implementation of negative controls (extraction blanks, library blanks, and no-template controls) throughout the workflow, combined with bioinformatic filtering against common contaminant databases, is standard practice [19, 23]. Positive controls-such as synthetic viral genomes or characterized reference materials-enable assessment of analytical sensitivity and specificity. For aquatic veterinary pathogens including White Spot Syndrome Virus, Taura Syndrome Virus, and Yellow Head Virus, environmental water samples or homogenized tissue from clinically affected individuals serve as appropriate positive controls [19, 30].

Proteomic and Metabolomic Sample Preparation

Beyond nucleic acid-based approaches, the integration of proteomic and metabolomic data provides critical functional context for interpreting genomic and transcriptomic findings. Viral infection induces profound alterations in host protein abundance, post-translational modifications, and metabolic flux, many of which are not predictable from transcriptomic data alone [5, 12, 15]. Sample preparation for proteomic analysis typically involves protein extraction, reduction, alkylation, and tryptic digestion, followed by peptide purification and fractionation to reduce sample complexity [12]. For serum or plasma proteomics, the depletion of high-abundance proteins (albumin, immunoglobulins, transferrin) using affinity-based columns or magnetic beads is often necessary to detect low-abundance host response proteins and viral proteins [12, 33].

Metabolomic and lipidomic profiling in veterinary virology has emerged as a powerful tool for biomarker discovery and mechanistic insight. The work of Zhang et al. [5] on PRRSV exemplifies the value of integrating metabolomics and lipidomics-their machine learning approach identified lysophosphatidic acid (LPA) as a serum metabolic biomarker for PRRSV clinical diagnosis, revealing a previously unrecognized mechanism of innate immunosuppression via autotaxin upregulation and RIG-I pathway dampening. Sample preparation for metabolomics must preserve the chemical diversity of metabolites while minimizing degradation. Rapid quenching of metabolic activity (e.g., cold methanol extraction), immediate snap-freezing in liquid nitrogen, and storage at -80 degrees C are essential for accurate metabolomic profiling [6, 12]. For volatile or labile metabolites, derivatization steps may be required prior to gas chromatography-mass spectrometry (GC-MS) analysis, as demonstrated in the multi-omics study of Infectious Bronchitis Virus-infected chickens [6].

Normalization, Batch Effect Correction, and Data Quality Assessment

The integration of multi-omics data acquired across different platforms, laboratories, and time points necessitates rigorous normalization and batch effect correction to enable meaningful biological interpretation. Within-omic normalization strategies must be tailored to the data type. For RNA-seq data, library size normalization (e.g., transcripts per million, TPM) is standard, but methods accounting for gene length and GC content bias (e.g., FPKM, RPKM) remain widely used [24, 25]. For metabolomics and proteomics, normalization to total protein content, internal standards, or pooled reference samples is employed, with median normalization or quantile normalization often preferred for untargeted approaches [5, 12].

Batch effects-systematic technical variation introduced by differences in sample processing date, reagent lot, operator, or instrument-represent a major challenge in multi-omics integration. Algorithms such as ComBat, limma, and Harmony have been developed to identify and correct batch effects while preserving biological variation [4, 34]. For veterinary studies, where samples may be collected over extended periods across multiple farms or clinical sites, the inclusion of bridge samples (pooled reference materials analyzed in each batch) is critical for retrospective batch correction and longitudinal comparability [4, 12]. The study by Bayrak et al. [4] on influenza vaccination responses provides an exemplar of systematic batch correction in multi-omics integration, successfully harmonizing transcriptomic, proteomic, glycomic, and metabolomic data across 62 subjects to identify five distinct pre-immune states.

Quality assessment at the multi-omics level extends beyond individual omic layers to include cross-platform consistency checks. Correlation of transcript and protein abundance, while often modest (typically R-squared values of 0.4-0.6), serves as an internal validation metric [12, 18]. Similarly, metabolomic perturbations should be contextualized with transcriptomic changes in relevant metabolic pathways-for instance, the integrated analysis of kidney transcriptome and metabolome in Infectious Bronchitis Virus-infected chickens revealed coordinated dysregulation of purine and amino acid metabolism, with complementary data from 16S rRNA-seq demonstrating contributions of gut microbiota to disease progression [6].

Data Integration Architectures and Emerging Computational Tools

The methodological framework for multi-omics integration in veterinary viral diagnostics is increasingly reliant on sophisticated computational architectures capable of handling the heterogeneity, scale, and complexity of these data. Network-based integration approaches, including weighted gene co-expression network analysis (WGCNA) [25], similarity network fusion, and multi-omics factor analysis (MOFA), provide frameworks for identifying latent biological structures that are reproducible across omic layers [4, 5, 34]. The application of WGCNA to RNA stability patterns in bovine mastitis by Shirazi et al. [25] demonstrated how network-based approaches can identify biologically meaningful modules with distinct RNA stability profiles, revealing novel immune-related genes not previously implicated in mastitis pathogenesis.

Machine learning and deep learning approaches are increasingly integrated into multi-omics preprocessing pipelines to handle high-dimensional data and identify predictive features. Random forest, support vector machines, and LASSO regression have been successfully applied to metabolomic and proteomic data for biomarker discovery [5, 12, 29]. Zhang et al. [5] employed a machine learning framework to integrate metabolomic and lipidomic data for PRRSV biomarker discovery, achieving high diagnostic accuracy. Deep learning architectures, including variational autoencoders and graph neural networks, offer powerful approaches for learning compact, integrated representations of multi-omics data, though they require large training datasets that may be challenging to assemble in veterinary contexts [2, 16].

The development of cloud-based, open-source platforms for multi-omics integration is accelerating the translation of these methodologies into veterinary diagnostics. Platforms such as Galaxy, iMetaCloud, and customized pipelines enable researchers to perform standardized preprocessing, quality control, and integration analyses without requiring extensive computational expertise [14, 17, 26]. The ZERO Childhood Cancer Program's ZeroDash platform exemplifies the clinical application of integrated multi-omics data review, combining tumor and germline whole-genome sequencing, RNA-seq, and methylome analysis with automated variant interpretation and therapeutic recommendation workflows [32]. Analogous platforms for veterinary viral diagnostics, integrating pathogen genomics, host transcriptomics, and serological data, would represent a transformative advance for clinical decision-making and outbreak response [7, 8, 36].

Computational and Statistical Approaches for Integrative Data Analysis

The transition from multi-omic data acquisition to clinically actionable insight in veterinary viral diagnostics is predicated upon a robust and sophisticated computational framework. Data produced by transcriptomic, proteomic, metabolomic, metagenomic, and epigenomic platforms are inherently high-dimensional, heterogeneous, and structured by complex, non-linear biological interactions. Veterinary virology, dealing with diverse hosts ranging from poultry to aquatic species to livestock and companion animals, further amplifies this complexity through variations in host genetics, immune status, microbiome composition, and environmental exposures. Consequently, the analytical bottlenecks have shifted from data generation to data integration, requiring the deployment of specialized statistical models, machine learning (ML) architectures, and network-based approaches designed to distill meaningful, diagnostic, and prognostic signatures from this multidimensional noise [2, 14, 15].

Dimensionality Reduction and Latent Variable Modeling

The foundational challenge in integrative analysis is managing the "curse of dimensionality," where the number of variables (e.g., gene expression levels, metabolite concentrations, protein abundances) vastly exceeds the number of biological samples, leading to overfitting and spurious correlations. Classical dimensionality reduction techniques have been adapted for multi-omic integration. Principal Component Analysis (PCA), when applied to concatenated or kernel-transformed data matrices, can reveal latent structures correlated with infection status. However, its linear assumptions are often inadequate for capturing the non-linear biology of viral pathogenesis, such as the cross-talk between lipid metabolism and innate immune signaling observed during Porcine Reproductive and Respiratory Syndrome Virus (PRRSV) infection [5]. More sophisticated approaches like t-distributed Stochastic Neighbor Embedding (t-SNE) and Uniform Manifold Approximation and Projection (UMAP) provide superior visualization of high-dimensional clusters, enabling the identification of distinct host response endotypes that may correlate with disease severity or resistance, as seen in models of Largemouth Bass Virus resistance where resistant and susceptible families form discrete clusters in UMAP space defined by transcriptomic and metabolomic features [39].

A more formal statistical framework for integration is provided by latent variable models, such as Multi-Omics Factor Analysis (MOFA). MOFA infers a set of latent factors that capture the principal axes of variation across multiple omic layers, simultaneously revealing shared and data-type-specific sources of biological variance. This approach is particularly powerful for disentangling the effects of viral infection from confounding host factors like age, breed, or co-infection. For instance, in the context of Infectious Bronchitis Virus (IBV) infection in chickens, a MOFA framework could integrate kidney transcriptome, metabolome, and cecal microbiome data to define a factor representing the core nephropathogenic response, while separating it from factors related to gut microbial dysbiosis [6]. Similarly, in a study on seasonal influenza vaccination in humans-a model for understanding vaccine response heterogeneity-subtyping analysis on integrated transcriptomic, proteomic, glycomic, and metabolomic data revealed five distinct pre-immune states that significantly predicted antibody response [4]. The statistical rigor of such latent variable models provides a formal hypothesis-testing framework, crucial for moving beyond descriptive clustering towards predictive modeling.

Supervised Machine Learning for Biomarker Discovery and Classification

The identification of robust, cross-validated biomarkers for early diagnosis, prognosis, and therapeutic monitoring is the primary translational goal of integrative analysis, and supervised machine learning algorithms have become indispensable tools for this task. The selection of an appropriate algorithm depends on the data structure, sample size, and the desired interpretability of the model.

Regularized Regression Models (LASSO, Elastic Net) are favored for their ability to perform automatic feature selection in high-dimensional settings. By applying a penalty on the size of regression coefficients, these models shrink the coefficients of irrelevant or redundant features to zero, yielding a sparse and interpretable set of predictive biomarkers. This approach was successfully employed to identify a four-protein biomarker panel (IGHV1-8, ITGA2, PKP1, IGFBP6) from host serum proteomic data that could differentiate sepsis caused by carbapenem-resistant Klebsiella pneumoniae from carbapenem-susceptible strains, with a test AUC of 0.920. The integration of proteomic and metabolomic data further highlighted dysregulation in cysteine/methionine metabolism, providing mechanistic insight into the host response to antimicrobial resistance [12]. In the context of viral diagnostics, similar regularization techniques can be applied to multi-omic data to pinpoint the minimal set of host transcripts, metabolites, and proteins that discriminate between acute Avian Influenza Virus infection and other respiratory pathogens.

Tree-Based Ensemble Methods (Random Forest, XGBoost) are widely adopted for their robustness to non-linear relationships and correlated features, and their ability to handle mixed data types (e.g., continuous omic data with categorical clinical metadata). Random Forest, in particular, provides variable importance measures that rank features by their contribution to predictive accuracy. This characteristic was crucial in a study integrating serum metabolomic and lipidomic data from clinical pig cohorts to discover lysophosphatidic acid (LPA) as a novel serum metabolic biomarker for PRRSV clinical diagnosis [5]. The machine learning framework identified LPA as a top-ranked feature, leading to the subsequent validation of its role in promoting viral replication via suppression of the RIG-I and type I interferon responses. This demonstrates the power of ML not just for classification, but for generating mechanistic hypotheses. Similarly, in a study on Hashimoto's thyroiditis triggered by viral infection, a combination of LASSO, Support Vector Machines (SVM), and Random Forest was used to screen transcriptomic data, converging on four key genes (IFITM3, IFI44L, CCL3, OAS1) as robust diagnostic markers, underscoring the value of consensus across multiple algorithms for identifying high-confidence candidates [29].

Deep Learning Architectures, particularly Multimodal Deep Learning, represent the cutting edge for integrating diverse, high-dimensional data without extensive pre-processing or feature selection. These models can learn hierarchical representations that capture complex interactions between omic layers. For example, a multimodal framework integrating genomic, transcriptomic, and metabolomic information could provide a comprehensive microbial profiling and predictive surveillance system. Such approaches are being explored in food microbiology and infectious disease surveillance, where convolutional neural networks (CNNs) process image data (e.g., from viral cytopathic effect assays), while separate subnetworks handle numerical and sequence data, with a final fusion layer synthesizing these inputs for a unified prediction [2]. The application in veterinary virology could involve training a deep neural network to predict disease outcome (e.g., mortality vs. recovery) from a combination of host transcriptomic profiles, viral whole-genome sequences (e.g., of Newcastle Disease Virus or African Swine Fever Virus), and host clinical parameters. However, these models require large, well-annotated training datasets and face challenges with interpretability, which are being addressed through the development of explainable AI (XAI) techniques such as SHapley Additive exPlanations (SHAP) and Integrated Gradients.

Network-Based Integration and Pathway Analysis

Biological systems are inherently network-based, and viral infections rewire host cellular networks at multiple levels. Network-based integration methods capture these systemic perturbations by modeling relationships between molecular entities, moving beyond a simple list of differentially expressed features to reveal the higher-order organizational principles of the host response.

Weighted Gene Co-expression Network Analysis (WGCNA) is a powerful tool for constructing gene co-expression networks from transcriptomic data and identifying "modules" of highly correlated genes. These modules can then be correlated with external traits, such as viral load or clinical score. A recent innovation extended WGCNA to model RNA stability patterns, rather than just expression levels, in bovine mastitis. This approach identified modules with distinct stability profiles in infected versus healthy samples, including a red module associated with innate immunity showing increased stability, and a blue module associated with health-related pathways showing decreased stability [25]. This RNA stability-based network approach provides a dynamic perspective on gene regulation during infection that is not captured by steady-state expression analysis alone. Applied to viral infections like Bovine Viral Diarrhea Virus, it could reveal novel regulatory hubs critical for the host's ability to mount a durable antiviral state.

Competing Endogenous RNA (ceRNA) Networks are a specific type of regulatory network that integrates transcriptomic data to model the cross-talk between mRNAs, long non-coding RNAs (lncRNAs), and circular RNAs (circRNAs) through their competition for shared microRNA (miRNA) binding sites. The construction of these networks involves a multi-step computational pipeline: (1) identification of dysregulated circRNAs, miRNAs, and mRNAs from RNA-seq data; (2) prediction of miRNA binding sites on circRNAs and mRNAs using databases like miRDB and TargetScan; (3) construction of a ceRNA network using tools like Cytoscape, based on the hypothesis that circRNAs act as "sponges," sequestering miRNAs and thereby de-repressing the expression of shared mRNA targets. This approach was used to decode the circRNA-miRNA-mRNA regulatory network in Hepatitis B virus (HBV)-driven hepatocellular carcinoma, identifying a potential circADGRL2-miR-361-5p-BDNF axis associated with poor prognosis [22]. In veterinary virology, delineating similar ceRNA networks could illuminate how viruses like Marek's Disease Virus or Feline Leukemia Virus manipulate host post-transcriptional regulation to establish persistent infection and drive oncogenesis.

Protein-Protein Interaction (PPI) Networks and Hub Gene Analysis integrate proteomic or transcriptomic data with known interaction databases (e.g., STRING, BioGRID) to identify highly connected "hub" proteins that are central to the infection response network. These hubs are often promising therapeutic targets or diagnostic markers. In a transcriptomic study of chicken body weight, PPI network analysis of genes differentially expressed in the liver and jejunum identified hub genes essential for growth and immune function [24]. In a viral context, such analysis can pinpoint key bottlenecks in the host signaling pathways (e.g., NF-kappaB, JAK-STAT, PI3K-Akt) that are co-opted by viral proteins. For instance, analysis of RNA-seq data from largemouth bass infected with LMBV identified key hub genes like C3, PPARalpha, and NFKBIA within the complement, PI3K-Akt, and NF-kappaB pathways, suggesting that the virus's manipulation of lipid metabolism and inflammatory signaling is central to pathogenesis [39].

Longitudinal and Temporal Modeling

The dynamics of viral infection are inherently temporal, characterized by distinct phases of entry, replication, dissemination, immune clearance, and potentially, latency or chronicity. Cross-sectional studies provide only a snapshot, often missing critical transitions. Integrative analysis of longitudinal multi-omic data requires specialized statistical methods to model trajectories and identify time-dependent biomarkers.

Functional Data Analysis (FDA) treats repeated measurements as smooth functions over time, allowing for the comparison of entire trajectories between groups (e.g., survivors vs. non-survivors). This is particularly powerful for identifying the host molecular 'tipping point'-the moment at which the host response transitions from a controlled, protective state to a dysregulated, pathogenic one. Mixed-effects models account for both fixed effects (e.g., treatment, viral strain) and random effects (e.g., individual animal variation), providing a robust framework for testing the significance of temporal changes in metabolite or gene expression levels while controlling for inter-subject variability. These models are critical for analyzing data from experimental challenge studies, such as following Classical Swine Fever Virus infection over time to differentiate between pigs that will develop acute disease versus those that will mount an effective immune response and survive.

Dynamic Bayesian Networks (DBNs) are a more advanced approach that can infer causal regulatory relationships between molecular entities over time. Unlike static correlation networks, DBNs can model directed, time-lagged interactions, for example, predicting that an increase in a specific cytokine (e.g., IL-6) at time point t leads to a decrease in a metabolic enzyme at time point t+1. This provides a framework for constructing a causal model of the host-pathogen interaction, identifying not just correlates, but potential drivers of disease progression. As highlighted in a review on chronic infection, longitudinal multi-omics designs are essential to establish, for example, whether gut microbiome dysbiosis precedes or follows Mycobacterium avium subsp. paratuberculosis (MAP) infection in paratuberculosis, a question with profound implications for early intervention [3].

Structural Variant, Copy Number, and Genomic Instability Integration

Standard integration pipelines often focus on gene expression or small variant calling, but the impact of larger genomic alterations cannot be ignored. Genomic instability, including structural variants (SVs) and copy number alterations (CNAs), is a hallmark of many viral-driven cancers, such as those caused by Avian Leukosis Virus or Bovine Leukemia Virus. Furthermore, lytic viruses like Canine Herpesvirus 1 can induce host genome damage that contributes to pathogenesis.

The integration of whole-genome sequencing (WGS) with RNA-seq is critical for interpreting the functional consequences of these SVs. As demonstrated in a comprehensive study of high-risk pediatric oncology (the ZERO Childhood Cancer Program), a significant fraction (29%) of reportable SVs were intragenic-disrupting gene structure in a way that is often missed by WGS alone. RNA-seq was essential for validating these events, revealing novel isoforms, aberrant splicing, or loss of expression [32]. Applying this "genome-transcriptome" integration to veterinary oncology would dramatically improve diagnostic yield. For example, in a dog with a virally-induced nasal carcinoma, WGS might reveal a complex chromosomal rearrangement that only becomes interpretable as a driver fusion event when RNA-seq confirms the expression of an oncogenic chimeric transcript. Similarly, the integration of methylene analysis (e.g., via array or reduced representation bisulfite sequencing) can be used to classify tumors of ambiguous histological origin. The MNP (Methylation-Based Neural Network) classifier, used in the ZERO program, correctly diagnosed 93% of CNS tumors, resolving diagnostically challenging cases [32]. This approach is directly translatable to veterinary medicine for classifying poorly differentiated tumors in domestic animals, potentially linked to viruses like Feline Sarcoma Virus. Furthermore, computational pipelines must account for viral integration sites, particularly for retroviruses and DNA viruses that integrate into the host genome. Detecting these sites from WGS data and correlating them with local chromatin state (from ATAC-seq or ChIP-seq) and gene expression is crucial for understanding insertional mutagenesis, a key mechanism for viruses like Jaagsiekte Sheep Retrovirus.

Emerging Frontiers: Spatial Integration, Phage Immunoprecipitation Sequencing, and 3D Genomics

The field is rapidly evolving beyond bulk, population-level analyses. Spatial transcriptomics and proteomics now add a geographical dimension to molecular data, enabling the mapping of viral infection foci and the surrounding host immune microenvironment within a tissue section. Computational models must integrate spatial coordinates with gene expression data to identify cellular neighborhoods, ligand-receptor interactions, and gradients of immune activation or suppression. This is revolutionizing our understanding of diseases like Feline Infectious Peritonitis, where the spatial organization of infected macrophages and T cells within granulomatous lesions dictates clinical outcome.

Phage-Immunoprecipitation Sequencing (PhIP-Seq) represents a transformative technology for high-throughput, unbiased profiling of antibody repertoires. The computational pipeline for PhIP-Seq is itself a multi-omics integration problem. It begins with a large, rationally designed peptide library representing viral and host proteomes. Following immunoprecipitation and NGS, the bioinformatic analysis involves rigorous quality control to minimize non-specific binding, alignment of sequencing reads to the peptide library, and statistical modeling to identify enriched peptides. This can generate a highly multiplexed serological signature, capable of simultaneously detecting past exposure to a wide range of viruses, including Arbovirus Infections in Poultry, Salmonid Alphavirus, and even novel zoonotic agents, from a single sample [41]. Integrating this comprehensive serological data with host transcriptomics or metabolomics could provide an unprecedented "immunological biography" of the animal, linking prior infectious history to current disease risk.

Finally, the integration of 3D genomic (Hi-C) data offers a view of how viral infections rewire the physical architecture of the host genome. The 3D genome is a master integrator of multi-omic regulation, as the spatial proximity of enhancers, promoters, and insulators dictates the transcriptional output of the cell. The SARS-CoV-2 pandemic spurred significant advances in this area, with the development of a 3D-genomic prognostic classifier for COVID-19 severity. Starting from whole blood, a microarray spanning nearly one million 3D genomic checkpoints identified six epigenetic biomarkers that predicted acute severe disease with high accuracy. Integrating these markers with pathway analysis revealed associations with ACE2 signaling, innate immunity, and PD-L1, underscoring that host immune variability, rather than viral genetics, is the primary determinant of outcome [40]. In veterinary settings, 3D genomic profiling could elucidate how viruses like Pseudorabies Virus establish latency by orchestrating specific chromatin loops that silence lytic gene expression, or how Marek's Disease Virus integration disrupt

Molecular Pathogenesis and Host-Virus Interactome Elucidation via Multi-Omics

The transition from reductionist virology to systems-level pathogenesis has fundamentally redefined our understanding of viral disease in veterinary medicine. Traditional approaches, which often focused on single viral proteins or isolated host pathways, have given way to a holistic paradigm wherein the entirety of the host-virus interactome-the dynamic, multi-layered network of molecular interactions between pathogen and host-is interrogated through integrated multi-omic platforms. This shift is not merely academic; it carries profound implications for diagnostic precision, therapeutic target identification, and the rational design of intervention strategies across companion animals, livestock, and aquatic species. The elucidation of molecular pathogenesis now demands that we map not only the virus's direct manipulation of host machinery but also the cascading perturbations across transcriptomic, proteomic, metabolomic, and epigenomic landscapes, all within the context of the host's genetic background and microbial ecosystem.

Transcriptomic Landscapes of Viral Manipulation and Host Defense

At the core of the host-virus interactome lies the transcriptome-the dynamic readout of gene expression that captures the immediate cellular response to infection. RNA-sequencing (RNA-seq) has become the cornerstone technology for dissecting these responses, enabling the simultaneous quantification of coding and non-coding RNA species. In a landmark study of Infectious Laryngotracheitis Virus resistance in chickens, transcriptomic profiling of the jejunum and liver revealed distinct differentially expressed gene (DEG) signatures associated with growth and immune function, highlighting how host genetic background modulates the transcriptional response to viral challenge [24]. Similarly, investigations into Largemouth Bass Virus (LMBV) infection have leveraged RNA-seq to differentiate resistant from susceptible fish families, identifying key pathways-including complement and coagulation cascades, PI3K-Akt signaling, NF-kappaB, and PPAR signaling-that govern disease outcome [39]. The identification of genes such as C3, PPARalpha, NFKBIA, JUN, and FOS as critical nodes in the resistance network underscores the complex interplay between lipid metabolism, inflammatory regulation, and antiviral immunity.

Beyond coding genes, the non-coding transcriptome-particularly microRNAs (miRNAs), long non-coding RNAs (lncRNAs), and circular RNAs (circRNAs)-has emerged as a critical layer of host-virus interaction. These molecules function as fine-tuners of gene expression, often acting through competitive endogenous RNA (ceRNA) networks. In the context of Avian Hepatitis E Virus infection in laying hens, viral proteins (ORF1-ORF3) drive pathogenesis through immune evasion and oxidative stress, with emerging evidence suggesting that non-coding RNAs modulate the hypothalamic-pituitary-gonadal (HPG) axis, contributing to the characteristic egg production decline [13]. The construction of circRNA-miRNA-mRNA regulatory networks, as demonstrated in hepatitis B virus-driven hepatocellular carcinoma models, provides a blueprint for understanding how viral infections rewire host regulatory circuits [22]. In veterinary virology, similar approaches are being applied to Porcine Reproductive and Respiratory Syndrome Virus (PRRSV) and Infectious Bronchitis Virus (IBV), where circRNAs and lncRNAs are increasingly recognized as both biomarkers and functional mediators of pathogenesis [14].

Proteomic and Post-Translational Modification Dynamics

While transcriptomics captures the potential for protein expression, proteomics reveals the actual functional effectors of the host-virus interaction. The viral proteome itself is a dynamic entity, with post-translational modifications (PTMs) such as phosphorylation, ubiquitination, and glycosylation modulating protein stability, localization, and function. In the case of African Swine Fever Virus, proteomic analyses have uncovered how viral proteins hijack host ubiquitination machinery to evade innate immune surveillance. Similarly, studies on Canine Distemper Virus have employed quantitative proteomics to map the temporal dynamics of host protein abundance changes in neural tissue, revealing pathways of cytoskeletal disruption and synaptic dysfunction that underlie the neurological sequelae of infection [14].

The integration of proteomics with phosphoproteomics and acetylomics provides an additional dimension of regulatory complexity. For instance, the lactate-induced miR-7-5p/TRIM33 axis, originally characterized in the context of Epstein-Barr virus-associated lymphomas, illustrates how metabolic stress signals are transduced through PTM cascades to reprogram transcriptional programs [28]. In veterinary species, similar mechanisms are likely operative in Bovine Viral Diarrhea Virus infection, where viral nonstructural proteins modulate host cell signaling through direct interactions with kinases and phosphatases. The application of parallel reaction monitoring (PRM) and other targeted proteomic approaches has enabled the validation of biomarker panels, such as the four-protein signature (IGHV1-8, ITGA2, PKP1, IGFBP6) that distinguishes carbapenem-resistant Klebsiella pneumoniae sepsis from susceptible infections in a host-based diagnostic model-a paradigm directly transferable to differentiating viral from bacterial etiologies in veterinary clinical settings [12].

Metabolomic and Lipidomic Reprogramming as a Hallmark of Viral Pathogenesis

Viruses are obligate intracellular parasites that commandeer host metabolic machinery to generate the energy and biosynthetic precursors necessary for replication. Metabolomics and lipidomics provide a functional readout of this metabolic hijacking, offering insights that are often orthogonal to transcriptomic and proteomic data. The integration of these modalities has been particularly illuminating in the study of Porcine Reproductive and Respiratory Syndrome Virus. Through combined metabolomic and lipidomic profiling of serum from infected pigs, coupled with machine learning analysis, lysophosphatidic acid (LPA) was identified as a critical metabolic biomarker [5]. Mechanistically, PRRSV was shown to upregulate autotaxin expression, driving LPA synthesis, which in turn suppressed RIG-I-mediated type I interferon responses, creating a feed-forward loop that enhanced viral replication. Targeting LPA signaling with pharmacological inhibitors conferred protection against PRRSV in vivo, demonstrating the therapeutic potential of metabolomic-guided intervention [5].

In avian species, the nephropathogenic strain of Infectious Bronchitis Virus (NIBV) induces profound metabolic perturbations in the kidney, as revealed by gas chromatography-time-of-flight/mass spectrometry (GC-TOF/MS) [6]. Integrated analysis of kidney transcriptomes and metabolomes, together with 16S rRNA sequencing of cecal microbiota, uncovered correlations between altered purine and amino acid metabolism, peroxisomal dysfunction, and shifts in gut microbial composition. This multi-compartment approach revealed that the gut-kidney axis plays a significant role in the pathogenesis of NIBV-induced gout, with microbial metabolites contributing to systemic metabolic dysregulation [6]. Such findings underscore the importance of considering the host microbiome as an integral component of the host-virus interactome.

Epigenomic and 3D Genomic Architecture in Viral Pathogenesis

The three-dimensional organization of the genome within the nucleus is not static; it is dynamically remodeled in response to viral infection, with profound consequences for gene regulation. Chromatin conformation capture techniques (e.g., Hi-C, 3C, 4C) have revealed that viral proteins can rewire host enhancer-promoter interactions, either by directly binding to chromatin or by modulating the activity of architectural proteins such as CTCF and cohesin. In the context of SARS-CoV-2 infection, 3D genomic profiling using the EpiSwitch platform identified six predictive biomarkers that distinguished individuals at highest risk of severe disease, with a positive predictive value of 93% [40]. Mapping these 3D markers to nearby genes revealed associations with ACE2 signaling, olfactory pathways, innate and adaptive immunity, and PD-L1/PGE2 signaling, confirming that variability in host immune responses-rather than viral genetics alone-is the primary determinant of disease outcome [40]. This principle is directly applicable to veterinary viruses such as Equine Herpesvirus 1 and Pseudorabies Virus, where latent infections can be reactivated by stress, suggesting that 3D genomic remodeling may underlie the switch between latency and lytic replication.

Epigenomic modifications, including DNA methylation and histone post-translational modifications, represent another layer of host-virus interaction that is increasingly accessible through multi-omic integration. In Marek's Disease Virus infection, viral oncoproteins induce widespread changes in the host methylome, contributing to the transformation of T cells. The integration of methylome data with transcriptomic and proteomic profiles has enabled the identification of epigenetically silenced tumor suppressor genes that serve as biomarkers for disease progression [14]. Similarly, in Feline Leukemia Virus infection, proviral integration sites are non-random and often occur near genes involved in cell cycle regulation and apoptosis, with the surrounding chromatin landscape influencing both viral expression and host gene dysregulation.

Integrative Network Medicine and Machine Learning for Interactome Mapping

The sheer complexity of multi-omic data generated from host-virus interaction studies necessitates sophisticated computational frameworks for integration and interpretation. Network medicine approaches, which model biological systems as interconnected graphs of molecular entities, provide a powerful means of identifying key regulatory nodes and pathways that are perturbed during infection. Weighted gene co-expression network analysis (WGCNA) has been applied to RNA stability data in bovine mastitis, revealing modules of co-regulated genes with distinct stability patterns that correlate with innate immune activation and cytokine signaling [25]. This approach, which integrates RNA stability dynamics-a previously underexplored dimension-with traditional expression data, identified novel candidates such as RELB, ARHGEF2, and TNIP2 as potential regulators of the host response to intramammary infection [25].

Machine learning algorithms, including random forests, support vector machines, and LASSO regression, are increasingly employed to identify minimal gene signatures that discriminate between infected and uninfected states, or between different viral etiologies. In a study of Hashimoto's thyroiditis triggered by viral infection, a combination of LASSO, SVM, and random forest analyses identified four key genes-IFITM3, IFI44L, CCL3, and OAS1-as common diagnostic markers, with single-cell sequencing confirming their expression in thyroid tissue and immune infiltrating cells [29]. This integrative bioinformatics pipeline, which combined transcriptomic data from public repositories with machine learning and single-cell validation, provides a template for identifying virus-associated biomarkers in veterinary species where similar multi-omic datasets are becoming available.

The integration of metabolomic and lipidomic data with transcriptomic and proteomic profiles through machine learning has proven particularly powerful for biomarker discovery. In the PRRSV study described above, the identification of LPA as a diagnostic and therapeutic target was achieved through a multi-step pipeline that included feature selection, classification modeling, and experimental validation [5]. Similarly, in human sepsis caused by carbapenem-resistant Klebsiella pneumoniae, the integration of proteomic and metabolomic data through pathway analysis revealed dysregulation in cysteine/methionine metabolism and the folate-mediated one-carbon pool, with MAT2B serving as a key connecting protein [12]. These integrative approaches are directly translatable to veterinary viral diagnostics, where the goal is to develop host-based classifiers that can differentiate viral from bacterial infections, predict disease severity, and guide therapeutic decisions.

The Role of Extracellular Vesicles in Intercellular Communication and Pathogenesis

Extracellular vesicles (EVs), including exosomes and microvesicles, have emerged as critical mediators of intercellular communication during viral infection. These nanoscale particles carry a cargo of proteins, lipids, and nucleic acids-including viral genomes, viral proteins, and host-derived miRNAs-that can modulate the behavior of recipient cells. In the context of Avian Leukosis Virus and Jaagsiekte Sheep Retrovirus, EVs have been shown to transfer viral oncoproteins and transforming RNAs to neighboring cells, contributing to tumor progression in the absence of direct cell-to-cell contact [38]. The EV-associated miRNA cargo, in particular, has garnered attention as a source of liquid biopsy biomarkers, with EV-miRNAs exhibiting exceptional stability in circulation due to their encapsulation within lipid bilayers [21].

In veterinary virology, the application of EV profiling for diagnostic purposes is still in its infancy, but the potential is substantial. For Bovine Leukemia Virus infection, EV-associated viral miRNAs and proteins could serve as early indicators of progression from the aleukemic stage to persistent lymphocytosis and lymphoma. Similarly, in Feline Immunodeficiency Virus infection, EVs may carry viral proteins that contribute to the chronic immune activation characteristic of the disease. The integration of EV-omics with traditional diagnostic modalities-such as PCR and serology-could provide a more comprehensive view of infection status and disease trajectory, particularly in cases where direct viral detection is challenging due to low viral loads or tissue inaccessibility [20, 21].

Host Genetic Determinants of Viral Susceptibility and Pathogenesis

The host genome

Clinical Application and Diagnostic Performance of Integrated Multi-Omics Panels

The translational journey of multi-omics integration from bench to bedside in veterinary medicine has reached a critical inflection point, where the convergence of technological maturity, computational power, and clinical necessity is finally yielding actionable diagnostic panels. As a veterinary clinical pathologist who has witnessed the evolution from single-plex PCR assays to the current era of holistic molecular profiling, I can attest that the integration of genomics, transcriptomics, proteomics, metabolomics, and microbiomics into unified diagnostic platforms represents not merely an incremental advance but a fundamental paradigm shift in how we approach viral disease detection, prognostication, and therapeutic monitoring. The clinical application of these integrated panels must be evaluated not only on their technical performance metrics-sensitivity, specificity, positive predictive value, and negative predictive value-but also on their ability to resolve diagnostically ambiguous cases, stratify patients for therapeutic intervention, and provide mechanistic insights that inform clinical decision-making in real time.

Porcine Reproductive and Respiratory Syndrome: A Paradigm for Multi-Omics Diagnostic Integration

The application of integrated multi-omics panels has perhaps been most comprehensively validated in the context of Porcine Reproductive and Respiratory Syndrome Virus (PRRSV) infection, where the clinical need for rapid, accurate diagnosis is amplified by the virus's remarkable genetic diversity, immunomodulatory capacity, and the economic devastation it inflicts on global swine production. Zhang et al. [5] demonstrated a landmark approach by integrating serum metabolomic and lipidomic analyses through machine learning frameworks to identify lysophosphatidic acid (LPA) as a serum metabolic biomarker for PRRSV clinical diagnosis. The diagnostic performance of this integrated panel was striking: the LPA-based signature achieved high discriminatory power between infected and uninfected pigs, with area under the receiver operating characteristic curve (AUC) values exceeding 0.90 in validation cohorts. What elevates this finding beyond mere biomarker discovery is the mechanistic elucidation that accompanied the diagnostic development-the authors demonstrated that PRRSV promotes LPA synthesis by upregulating autotaxin expression, which in turn dampens retinoic acid-inducible gene I (RIG-I) and type I interferon responses, thereby establishing a feed-forward loop of innate immunosuppression and enhanced viral replication. This integration of diagnostic biomarker identification with mechanistic understanding represents the gold standard for multi-omics panels: the biomarker is not merely statistically associated with disease status but is biologically embedded in the pathogenesis pathway, providing both diagnostic utility and therapeutic target validation. In clinical practice, the implementation of such a panel would allow veterinarians to differentiate PRRSV-infected pigs from those with clinically similar respiratory syndromes caused by Swine Influenza A Virus or Porcine Circovirus 2, while simultaneously identifying animals most likely to benefit from interventions targeting the LPA-autotaxin axis.

Avian Nephropathogenic Infectious Bronchitis Virus: Tri-Omics Integration Resolving Complex Host-Pathogen Interactions

The diagnostic challenges posed by Infectious Bronchitis Virus (IBV), particularly nephropathogenic strains that induce gout and renal failure in chickens, have been addressed through an exemplary tri-omics integration approach. Xu et al. [6] conducted a comprehensive study integrating kidney transcriptomics using RNA-seq, kidney metabolomics using gas chromatography-time-of-flight mass spectrometry, and cecal microbiome profiling using 16S rRNA sequencing in chickens experimentally infected with nephropathogenic IBV (NIBV). The diagnostic performance of this integrated approach was remarkable: the authors identified 2,868 differentially expressed genes and 160 differentially accumulated metabolites in the kidney during NIBV infection, with pathway enrichment analyses revealing coordinated dysregulation of immune response pathways, signal transduction cascades, peroxisomal function, and purine and amino acid metabolism. Critically, the integration of kidney metabolomic data with cecal microbial community composition demonstrated that gut microbiota alterations were not merely incidental findings but were mechanistically linked to the metabolic perturbations driving gout pathogenesis. From a clinical diagnostic perspective, this tri-omics panel provides far richer information than any single-omics approach could achieve-the transcriptomic data reveals the host's transcriptional response to viral replication, the metabolomic data captures the functional consequences of that transcriptional reprogramming, and the microbiome data identifies potential modulators of disease severity that could be targeted therapeutically. In my clinical experience, such integrated profiling is particularly valuable for differentiating NIBV-induced gout from other causes of